top of page

Accessibility Statement for Medical Enterprises

Conformance status

The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA. Medical Enterprises is partially conformant with WCAG 2.1 level AA. Partially conformant means that some parts of the content do not fully conform to the accessibility standard.

www.synergo-medical.com is committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability. We aim to adhere as closely as possible to the Web Content Accessibility Guidelines (WCAG 2.0, Level AA), published by the World Wide Web Consortium (W3C). These guidelines explain how to make Web content more accessible for people with disabilities. Conformance with these guidelines will help make the web more user friendly to everyone. Whilst www.synergo-medical.com strive to adhere to the guidelines and standards for accessibility, it is not always possible to do so in all areas of the website and we are currently working to achieve this. Be aware that due to the dynamic nature of the website, minor issues may occasionally occur as it is updated regularly. 
 

Feedback

We welcome your feedback on the accessibility of Medical Enterprises. Please let us know if you encounter accessibility barriers on Medical Enterprises:

  • Phone: +31206423719

  • E-mail: info@synergo-medical.com

  • Visitor Address: 147A Amsterdamseweg

  • We try to respond to feedback within 3 business days.

    Synergo  per il Trattamento del Tumore vescicale Non-Muscolo Invasivo
    Synergo  - Therapie bei Nicht-Muskelinvasivem Blasenkrebs (Harnblasenkarzinom)
    Synergo Kasa İnvaze Olmayan Mesane Kanseri (KIOMK) Tedavisi İçin Radyofrekans Kaynakli Termo-Kemoterapi Uygulamasi
    Synergo RF technology |
    Bladder preservation |
    Bladder cancer treatment
    Radiofrequency-induced hyperthermia |
    Microwave-induced hyperthermia |
    Chemohyperthermia |
    BCG unresponsive |
    Cystectomy
    علاج سينرغو (Synergo): فرط الحرارة الموضعي الناتج عن الميكروويف (التردد الراديوي) مع علاج كيميائي 
    Технология SYNERGO для лечения мышечно-неинвазивного рака мочевого пузыря

    non-muscle invasive bladder cancer |

    Synergo® Microwave (RF)-Induced Thermochemotherapy treatment for Bladder Cancer
    site accessability logo WCAG 2.1AA
    Informace pro pacienty s diagnózou neinvazivního karcinomu močového měchýře a léčbou přípravkem Synergo®
    סרטן שלפוחית השתן וטיפול סינרגו
    Niet-spierinvasieve blaaskanker: De Synergo® Behandeling
    bottom of page